Sep 13, 2019 | Controlled Release, Drug Bioavailability, Main Blog, Peptide |
Beyond 2020, the global Peptide Therapeutics market is expected to eclipse $42 billion. This dramatic market increase is driven by both growing incidences of cardiovascular and metabolic diseases, and technological enhancements in peptide synthesis that include...
Jul 8, 2019 | Main Blog, Peptide |
There are a number of pharmacological and economical benefits to developing controlled and modified release drug products. Following the 505(b)(2) pathway allows companies to make modest changes to an already approved drug and get continued market exclusivity for a...
Jul 3, 2019 | Controlled Release, Main Blog, Peptide |
Big Picture Outlook According to markets & Markets, the drug delivery technology market is expected to reach USD $1,669.4 Billion by 2020 from USD $1,179.2 Billion in 2016, growing at a CAGR of 7.2% during the forecast period. Geographically, Asia is projected to...
Oct 3, 2018 | Main Blog |
The drug development model is in need of a drastic shakeup. COVID-19 has only accelerated this. Now more than ever is there a need to initiate innovative formulation, delivery and development approaches in order to improve bioavailability and therapeutic...
Jun 14, 2017 | Main Blog, Peptide |
Having worked with many pharmaceutical and biotech companies over the last few years as the co-organizer of our annual Controlled & Modified Drug Release Summit, the need for many of them to explore opportunities and invest in controlled release technologies...
Recent Comments